1,3,5-triaza-7-phosphaadamantane has been researched along with naproxen in 1 studies
| Studies (1,3,5-triaza-7-phosphaadamantane) | Trials (1,3,5-triaza-7-phosphaadamantane) | Recent Studies (post-2010) (1,3,5-triaza-7-phosphaadamantane) | Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) |
|---|---|---|---|---|---|
| 44 | 0 | 33 | 4,551 | 1,057 | 1,429 |
| Protein | Taxonomy | 1,3,5-triaza-7-phosphaadamantane (IC50) | naproxen (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 1.1642 | |
| Hormone-sensitive lipase | Rattus norvegicus (Norway rat) | 1.2 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 4.0203 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 3.8725 | |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 0.06 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 0.5867 | |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 1.26 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 3.36 | |
| Solute carrier family 22 member 6 | Homo sapiens (human) | 5.8 | |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 0.06 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fadare, OA; Olasunkanmi, LO; Tabrizi, L | 1 |
1 other study(ies) available for 1,3,5-triaza-7-phosphaadamantane and naproxen
| Article | Year |
|---|---|
Experimental and theoretical investigations of cyclometalated ruthenium(ii) complex containing CCC-pincer and anti-inflammatory drugs as ligands: synthesis, characterization, inhibition of cyclooxygenase and in vitro cytotoxicity activities in various can
Topics: Adamantane; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coordination Complexes; Cyclooxygenase Inhibitors; Drug Stability; HEK293 Cells; Humans; Ibuprofen; Ligands; MCF-7 Cells; Molecular Docking Simulation; Molecular Structure; Naproxen; Organophosphorus Compounds; Reactive Oxygen Species; Ruthenium | 2019 |